Literature DB >> 29555311

Enhanced production of soluble tumor necrosis factor-related apoptosis-inducing ligand in Escherichia coli using a novel self-cleavable tag system Fh8-ΔI-CM.

Min Zhang1, Zhanqing Wang1, Lili Chi2, Jing Sun3, Yaling Shen4.   

Abstract

Escherichia coli is an essential host for large-scale expression of heterologous polypeptides. However, further applications are limited by the formation of potential protein aggregates. In this work, we developed a novel on-column tag removal and purification system based on Fh8 hydrophobic interaction chromatography purification and ΔI-CM self-cleavage to obtain soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). We evaluated several methods to improve TRAIL solubility and finally demonstrated that the Fh8 tag was a powerful solubility enhancer. Finally, we replaced the tobacco etch virus (TEV) protease site with a ΔI-CM self-cleavage intein to simplify the purification process. The released soluble TRAIL purity and yield reached 98.4% and 82.1 mg/L in shake flasks, respectively. Thus, the Fh8-ΔI-CM system enhanced target protein solubility by Fh8, enabled on-column tag removal and purification based on Fh8 calcium-binding properties and ΔI-CM self-cleavage properties, and promoted the release of highly active protein with high yield and purity. Overall, our findings suggest that this Fh8-ΔI-CM system could be used as a novel solubility-inducing and purification fusion tag for protein production in E. coli.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fh8-Δ; I-CM tag; Protein expression and purification; Self-cleavable inteins; Tumor necrosis factor-related apoptosis-inducing ligand

Mesh:

Substances:

Year:  2018        PMID: 29555311     DOI: 10.1016/j.pep.2018.03.005

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  3 in total

1.  Application of an Autoinduction Strategy to Optimize the Heterologous Production of an Antitumor Bispecific Fusion Protein Based on the TRAIL Receptor-Selective Mutant Variant in Escherichia coli.

Authors:  Alina Isakova; Artem Artykov; Yekaterina Vorontsova; Dmitry Dolgikh; Mikhail Kirpichnikov; Marine Gasparian; Anne Yagolovich
Journal:  Mol Biotechnol       Date:  2022-09-12       Impact factor: 2.860

2.  Strategies for the Production of Soluble Interferon-Alpha Consensus and Potential Application in Arboviruses and SARS-CoV-2.

Authors:  Felipe Grabarz; Alexandre Paulo Yague Lopes; Flávia Ferreira Barbosa; Giovana Cappio Barazzone; Jademilson Celestino Santos; Viviane Fongaro Botosso; Soraia Attie Calil Jorge; Ana Lucia Tabet Oller Nascimento; Renato Mancini Astray; Viviane Maimoni Gonçalves
Journal:  Life (Basel)       Date:  2021-05-21

3.  GroEL/ES mediated the in vivo recovery of TRAIL inclusion bodies in Escherichia coli.

Authors:  Zhanqing Wang; Min Zhang; Xin Lv; Jiying Fan; Jian Zhang; Jing Sun; Yaling Shen
Journal:  Sci Rep       Date:  2018-10-25       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.